NOVEL FORMULATIONS BASED ON ANTISED MILK LYOPHILISATES AND HUMAN PROTEAS INHIBITORS, INDICATED IN MILK INTOLERANCE, ALLERGIC AND INFECTIOUS INFLAMMATION

摘要

The innovation concerns novel medicinal compositions intended for human and animal medicine, constituted for example by a lyophilizate of donkey milk intimately mixed with a lyophilizate of one or more natural inhibitors of human protease enzymes, such as ovomucoid and ovoinhibitor, extracts of the white of the quail egg of the species Coturnix coturnix japonica strain B.Mina, for oral administration, for example. This combination potentiates the effects of each of the active ingredients, benefits from the surprising technical effect obtained by lyophilization and induces a strong synergy of action, in their nutritional activities, anti-inflammatory specific (allergy) and non-specific (infections) of the adult and the child. Innovation is indicated in the prevention and treatment of oculo-nasal, respiratory, dermatological or other pathologies such as malnutrition, intolerance to cow's milk and its consequences, and to rebalance the immune system. The formulation proposed for capsules, for example, may also be used for the manufacture of food supplements, cosmetological products, or even other products, of all pharmaceutically acceptable dosage forms, this formulation being proposed for information only and is not not restrictive. This formulation contains the milk of a donkey aged at least four years, and natural inhibitors of human proteases that are present in the animal kingdom, plant and parasitic or are from all other sources.